Clinical features and histological findings are potential indicators of activity in lesions of common vitiligo

British Journal of Dermatology

Volumn 168, Issue 2, 2013, Pages 265-271

  Benzekri, Laila ^a   Gauthier, Y ^b   Hamada, S ^a   Hassam, B ^a  

^a IBN SINA HOSPITAL   (Morocco)

^b HÔPITAL SAINT ANDRÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; DISEASE ACTIVITY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOLOGY; MALE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SKIN BIOPSY; SKIN EXAMINATION; VITILIGO;

ADULT; BIOPSY; FEMALE; HUMANS; MALE; PROSPECTIVE STUDIES; SKIN; VITILIGO;

EID: 84873118678     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.12034     Document Type: Article

References (37)

1. Malakar S, Lahiri K, Malakar RS,. How unstable is the concept of stability in surgical repigmentation of vitiligo? Dermatology 2000; 201: 182-3.
2. Hann SK, Park YK, Lee KG, et al. Epidermal changes in active vitiligo. J Dermatol 1992; 19: 217-22.
3. Ahn SK, Choi EH, Lee SH, et al. Immunohistochemical studies from vitiligo-comparison between active and inactive lesions. Yonsei Med J 1994; 35: 404-10.
4. Sharquie KE, Mehenna SH, Naji AA, Al-Azzawi H,. Inflammatory changes in vitiligo. Am J Dermatopathol 2004; 26: 108-12.
5. Attili VR, Attili SK,. Lichenoid inflammation in vitiligo: a clinical and histopathologic review of 210 cases. Int J Dermatol 2008; 47: 663-9.
6. Le Poole IC, van den Wijngaard V, Westerhof W, Das PK,. Presence of T cells and macrophages in inflammatory vitiligo skin parallels melanocyte disappearance. Am J Pathol 1996; 148: 1219-28.
7. Birbeck EA,. An electron microscopic study of basal melanocytes and Langerhans cells in vitiligo. J Invest Dermatol 1961; 37: 51-64.
8. Galadari E, Mehregan AH, Hashimoto K,. Ultrastructural study of vitiligo. Int J Dermatol 1993; 32: 269-71.
9. Aslanian FMP, Figueira AL, Cuzzi T, et al. Histopathology of vitiligo. In: Vitiligo (, Picardo M, Taïeb A, eds). Berlin, Heidelberg: Springer-Verlag, 2010; 25-32.
10. Falabella R, Arrunateguy A, Barona MI,. The minigrafting test for vitiligo detection of stable lesions for melanocyte transplantation. J Am Acad Dermatol 1995; 32: 228-32.
11. Hann SK, Chun WH, Park YK,. Clinical characteristics of progressive vitiligo. Int J Dermatol 1997; 36: 353-5.
12. Ortonne JP, Moscher DB, Fitzpatrick TB,. Disorders with circumscribed hypomelanosis. In: Vitiligo and Other Hypomelanoses of Hair and Skin (, Ortonne JP, Moscher DB, Fitzpatrick TB, eds). New York: Plenum Medical Book Co, 1983; 129-310.
13. Koga M, Tango T,. Clinical features and course of type A and type B vitiligo. Br J Dermatol 1988; 19: 118-23.
14. Gauthier Y, Cario Andre M, Taïeb A,. A critical appraisal of vitiligo etiologic theories: is melanocyte loss a melanocytorrhagy? Pigment Cell Res 2003; 16: 322-32.
15. Garb J, Wise F,. Vitiligo with raised borders. Arch Derm Syphilol 1948; 58: 149-53.
16. Buckley WR, Lobitz WC Jr,. Vitiligo with a raised inflammatory border. AMA Arch Derm Syphilol 1953; 67: 316-20.
17. Lee D, Lazova R, Bolognia JL,. A figurate papulosquamous variant of inflammatory vitiligo. Dermatology 2000; 200: 270-4.
18. Hann SK, Kim S, Yoo JH, Chun YS,. Clinical and histopathologic characteristics of trichrome vitiligo. J Am Acad Dermatol 2000; 42: 589-96.
19. Gopinathan T,. A study of the lesion of vitiligo. Arch Dermatol 1965; 91: 397-402.
20. Moellmann G, Klein-Angerer S, Scollay DA, et al. Extracellular granular material and degeneration of keratinocytes in the normally pigmented epidermis of patients with vitiligo. J Invest Dermatol 1982; 79: 321-30.
21. Bhawan J, Bhutani LK,. Keratinocyte damage in vitiligo. J Cutan Pathol 1983; 10: 207-12.
22. Montes LF, Abulafia J, Wilborn WH, et al. Value of histopathology in vitiligo. Int J Dermatol 2003; 42: 57-61.
23. Van den Born JG, Konijnenberg D, Dellemjin AM, et al. Destruction of skin melanocytes by perilesional T cells from vitiligo patients. J Invest Dermatol 2009; 129: 2220-32.
24. Harris JE, Harris TH, Weninger W, et al. A mouse model of vitiligo with focused epidermal depigmentation requires IFN-γ for autoreactive CD8+ T-cell accumulation in the skin. J Invest Dermatol 2012; 132: 1869-76.
25. Horn TD, Abanmi A,. Analysis of the lymphocyte infiltrate in a case of vitiligo. Am J Dermatopathol 1997; 19: 400-2.
26. Ongenae K, Van Geel N, Naeyaert JM,. Evidence for an autoimmune pathogenesis of vitiligo. Pigment Cell Res 2003; 16: 90-100.
27. Badri AM, Todd PM, Garioch JJ, et al. An immunohistological study of cutaneous lymphocytes in vitiligo. J Pathol 1993; 170: 149-55.
28. Rao A, Gupta S, Dinda AK, et al. Study of clinical, biochemical and immunological factors determining stability of disease with generalized vitiligo undergoing melanocyte transplantation. Br J Dermatol 2012; 166: 1230-6.
29. Speeckaert R, nan Geel N, Vermaelen KV, et al. Immune reaction in benign and malignant melanocyte lesions: lessons for immunotherapy. Pigment Cell Melanoma Res 2011; 24: 334-44.
30. Kemp EH,. Humoral antibodies. In: Vitiligo (, Picardo M, Taïeb A, eds). Berlin, Heidelberg: Springer-Verlag, 2010; 248-56.
31. Klarquist J, Dennan CJ, Hernandez C, et al. Reduced skin homing by functional Tregs in vitiligo. Pigment Cell Melanoma Res 2010; 23: 276-86.
32. Ben Ahmed M, Zaraa I, Rekik R, et al. Functional defects of peripheral regulatory T lymphocytes in patients with progressive vitiligo. Pigment Cell Melanoma Res 2012; 25: 99-109.
33. Pretti Aslanian FM, Noé RA, Cuzzi T, Filgueira AL,. Abnormal histological findings in active vitiligo include the normal-appearing skin. Pigment Cell Res 2007; 20: 144-5.
34. Bos JD, Zonnevald I, Das PK, et al. The skin immune system (SIS): distribution and immunophenotype of lymphocyte subpopulations in normal human skin. J Invest Dermatol 1987; 88: 569-73.
35. Le Poole I, Norris DA,. Cell-mediated immunity. In: Vitiligo (, Picardo M, Taïeb A, eds). Berlin, Heidelberg: Springer-Verlag, 2010; 256-65.
36. Lahiri K, Malakar S,. The concept of stability of vitiligo: a reappraisal. Indian J Dermatol 2012; 57: 83-9.
37. Ezzedine K, Lim HW, Suzuki T, et al. Revised classification/nomenclature of vitiligo and related issues: the Vitiligo Global Issues Consensus Conference. Pigment Cell Melanoma Res 2012; 25: E1-13.